Plethora Solutions Ltd.
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Subsidiary
- Employees
- -
- Market Cap
- -
Clinical Trials
10
Active:4
Completed:6
Trial Phases
2 Phases
Phase 1:5
Phase 2:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
Phase 1
5 (62.5%)Phase 2
3 (37.5%)PSD502 in Subjects With Premature Ejaculation
- First Posted Date
- 2018-07-06
- Last Posted Date
- 2022-07-05
- Lead Sponsor
- Plethora Solutions Ltd
- Target Recruit Count
- 121
- Registration Number
- NCT03578783
- Locations
- 🇺🇸
Achieve Clinical Research, Birmingham, Alabama, United States
🇺🇸Coastal Clinical Research, Mobile, Alabama, United States
🇺🇸Skyline Urology, Sherman Oaks, California, United States
A Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment of Premature Ejaculation
Phase 1
Completed
- Conditions
- Premature Ejaculation
- Interventions
- Drug: Intervention ADrug: Intervention B
- First Posted Date
- 2010-08-18
- Last Posted Date
- 2016-08-10
- Lead Sponsor
- Plethora Solutions Ltd
- Target Recruit Count
- 30
- Registration Number
- NCT01184105
A Safety and Tolerability Study of Administration of PSD502
Phase 1
Completed
- Conditions
- Premature Ejaculation
- Interventions
- Drug: Intervention ADrug: Intervention BDrug: Intervention CDrug: Intervention E
- First Posted Date
- 2010-08-17
- Last Posted Date
- 2016-08-10
- Lead Sponsor
- Plethora Solutions Ltd
- Target Recruit Count
- 21
- Registration Number
- NCT01183208
- Locations
- 🇬🇧
Bio-Kinetic Europe Limited, Belfast, United Kingdom
Efficacy, Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment Premature Ejaculation
Phase 2
Completed
- Conditions
- Premature Ejaculation
- Interventions
- Drug: PSD502, contains a mixture of lidocaine and prilocaineDrug: Placebo
- First Posted Date
- 2007-11-12
- Last Posted Date
- 2016-09-26
- Lead Sponsor
- Plethora Solutions Ltd
- Target Recruit Count
- 256
- Registration Number
- NCT00556478
- Locations
- 🇺🇸
Department of Urology, University of North Carolina, Chapel Hill, North Carolina, United States
Phase I Study of PSD502 (Lidocaine Prilocaine Spray) Applied to the Glans Penis up to Three Times a Day for 21 Days in Healthy Male Volunteers
Phase 1
Completed
- Conditions
- Healthy
- First Posted Date
- 2007-06-08
- Last Posted Date
- 2010-07-15
- Lead Sponsor
- Plethora Solutions Ltd
- Target Recruit Count
- 16
- Registration Number
- NCT00483990
- Locations
- 🇺🇸
PRA International - Clinical Pharmacology Center, Lenexa, Kansas, United States
News
No news found